6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
11m ago	FatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
37m ago	Angle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
37m ago	Century Complete Announces New Homes Coming Soon to Fleming Island, FL
38m ago	Sprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
38m ago	Tambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning

About

Cytokinetics Inc (NASDAQ:CYTK) — investor relations, events, news, and company updates on 6ix.

Latest News

Cytokinetics to Announce First Quarter Results on May 5, 2026

Cytokinetics to Participate in the 25th Annual Needham Virtual Healthcare Conference

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo

Cytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update

Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Financials

Revenue

$88.04 M

Market Cap

$8.22 B

EPS

-6.54

Community Chat

Ask AI